Literature DB >> 15069575

[Surgery for macular edema].

C Haritoglou1, A Kampik.   

Abstract

At the end of the nineteenth century, "macular edema" had already been recognized as a pathological condition. The main causes for macular edema are vascular, inflammatory, degenerative, and congenital diseases or trauma. The therapeutic approaches have changed along with the increasing knowledge on the underlying causes of action during the last few years and include laser treatment as well as surgical interventions. Pars plana vitrectomy (including ILM peeling) seems beneficial in cases of macular edema that are associated with alterations of the vitreous or the vitreoretinal interface. For the treatment of chronic macular edema, intravitreal application of agents such as triamcinolone has become an option.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15069575     DOI: 10.1007/s00347-004-1027-z

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  56 in total

1.  Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid.

Authors:  S D Pendergast; T S Hassan; G A Williams; M S Cox; R R Margherio; P J Ferrone; B R Garretson; M T Trese
Journal:  Am J Ophthalmol       Date:  2000-08       Impact factor: 5.258

2.  Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis.

Authors:  S Young; G Larkin; M Branley; S Lightman
Journal:  Clin Exp Ophthalmol       Date:  2001-02       Impact factor: 4.207

3.  Epiretinal and vitreous membranes. Comparative study of 56 cases.

Authors:  A Kampik; K R Kenyon; R G Michels; W R Green; Z C de la Cruz
Journal:  Arch Ophthalmol       Date:  1981-08

4.  Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane.

Authors:  A Gandorfer; E M Messmer; M W Ulbig; A Kampik
Journal:  Retina       Date:  2000       Impact factor: 4.256

5.  Surgical treatment for severe diabetic macular edema with massive hard exudates.

Authors:  C M Yang
Journal:  Retina       Date:  2000       Impact factor: 4.256

6.  Indocyanine green-assisted peeling of the internal limiting membrane may cause retinal damage.

Authors:  A Gandorfer; C Haritoglou; C A Gass; M W Ulbig; A Kampik
Journal:  Am J Ophthalmol       Date:  2001-09       Impact factor: 5.258

7.  Diabetic maculopathy. A critical review highlighting diffuse macular edema.

Authors:  G H Bresnick
Journal:  Ophthalmology       Date:  1983-11       Impact factor: 12.079

8.  Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane.

Authors:  J W Harbour; W E Smiddy; H W Flynn; P E Rubsamen
Journal:  Am J Ophthalmol       Date:  1996-04       Impact factor: 5.258

9.  [Surgery of idiopathic epimacular membranes. Prognostic factors].

Authors:  A Gaudric; D Cohen
Journal:  J Fr Ophtalmol       Date:  1992       Impact factor: 0.818

10.  Intravitreal injection of triamcinolone for diffuse diabetic macular edema.

Authors:  Jost B Jonas; Ingrid Kreissig; Antje Söfker; Robert F Degenring
Journal:  Arch Ophthalmol       Date:  2003-01
View more
  1 in total

1.  [Classification of biomedical research reports as a reference for evidence-based medicine in ophthalmology. A survey considering as example the journal Der Ophthalmologe].

Authors:  H P N Scholl; M Fleckenstein; T U Krohne; F G Holz
Journal:  Ophthalmologe       Date:  2005-12       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.